doi: 10.3803/EnM.2021.102 Summary Keywords GLP-1 receptor agonists, endocrine, cardiovascular, neurological, cancer Citation Zhao X, Wang M, Wen Z, Lu Z, Cui L, Fu C, Xue H, Liu Y and Zhang Y (2021) GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
- Kimutattk, hogy a GLP-1 gygyszerek visszaszortjk a gyulladst s a mj hegesedsnek folyamatt, ami elnys lehet a zsrmjbl kiindul mjbetegsgek megelzsben
What are Biote products
View Profile Book Your Appointment Today
With the development of the first GIP/GLP-1 co-agonist, tirzepatide, there has been an exponential increase in the effectiveness of incretin-mimetic pharmacological therapy for weight control in obese patients with and without diabetes